Apellis Pharmaceuticals, Inc. (APLS) Social Stream
APELLIS PHARMACEUTICALS INC (APLS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering APELLIS PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 12 | $116 | $28 | $68.307 | $39.67 | 72.19% |
| 2021-11-12 | 12 | $116 | $28 | $67.23 | $39.67 | 69.47% |
| 2021-11-17 | 11 | $116 | $28 | $67.692 | $39.67 | 70.64% |
| 2021-11-24 | 12 | $116 | $28 | $68.076 | $39.67 | 71.61% |
| 2021-11-29 | 12 | $116 | $28 | $67.615 | $39.67 | 70.44% |
| 2021-12-15 | 13 | $116 | $28 | $68.785 | $39.67 | 73.39% |
| 2022-01-05 | 13 | $116 | $28 | $69 | $39.67 | 73.93% |
| 2022-01-11 | 13 | $112 | $28 | $69.142 | $39.67 | 74.29% |
| 2022-01-26 | 13 | $112 | $34 | $69.571 | $39.67 | 75.37% |
| 2022-03-02 | 13 | $114 | $34 | $69.714 | $39.67 | 75.73% |
| 2022-03-16 | 13 | $114 | $34 | $69.5 | $39.67 | 75.2% |
| 2022-03-17 | 13 | $114 | $34 | $70.428 | $39.67 | 77.53% |
| 2022-03-22 | 13 | $114 | $34 | $70.071 | $39.67 | 76.63% |
| 2022-04-04 | 12 | $114 | $34 | $70.23 | $39.67 | 77.04% |
| 2022-04-14 | 12 | $114 | $34 | $70.23 | $39.67 | 77.04% |
| 2022-04-19 | 12 | $114 | $34 | $70.076 | $39.67 | 76.65% |
| 2022-04-21 | 12 | $114 | $34 | $70.307 | $39.67 | 77.23% |
| 2022-04-28 | 12 | $114 | $39 | $70.692 | $39.67 | 78.2% |
| 2022-05-10 | 12 | $102 | $40 | $69.923 | $39.67 | 76.26% |
| 2022-05-12 | 12 | $102 | $40 | $70.23 | $39.67 | 77.04% |
| 2022-06-01 | 12 | $102 | $40 | $70.384 | $39.67 | 77.42% |
| 2022-06-17 | 13 | $102 | $40 | $69.642 | $39.67 | 75.55% |
| 2022-07-25 | 13 | $102 | $40 | $72.266 | $39.67 | 82.17% |
| 2022-08-09 | 13 | $113 | $40 | $74.2 | $39.67 | 87.04% |
| 2022-08-13 | 13 | $113 | $40 | $74.333 | $39.67 | 87.38% |
| 2022-08-24 | 13 | $113 | $40 | $75.733 | $39.67 | 90.91% |
| 2022-09-06 | 13 | $113 | $40 | $76.4 | $39.67 | 92.59% |
| 2022-10-04 | 13 | $113 | $40 | $78.769 | $39.67 | 98.56% |
| 2022-10-17 | 13 | $113 | $40 | $78.153 | $39.67 | 97.01% |
| 2022-10-21 | 13 | $123 | $40 | $78.923 | $39.67 | 98.95% |
| 2022-11-04 | 13 | $123 | $40 | $78.692 | $39.67 | 98.37% |
| 2022-11-08 | 13 | $123 | $40 | $77.923 | $39.67 | 96.43% |
| 2022-11-10 | 13 | $123 | $40 | $74.615 | $39.67 | 88.09% |
| 2022-11-18 | 13 | $123 | $40 | $74.461 | $39.67 | 87.7% |
| 2023-01-03 | 13 | $123 | $40 | $72.461 | $39.67 | 82.66% |
| 2023-01-26 | 12 | $123 | $40 | $75.166 | $39.67 | 89.48% |
| 2023-02-16 | 12 | $123 | $40 | $74.916 | $39.67 | 88.85% |
| 2023-02-21 | 14 | $123 | $47 | $77.769 | $39.67 | 96.04% |
| 2023-02-22 | 14 | $123 | $51 | $84.142 | $39.67 | 112.1% |
| 2023-02-23 | 14 | $139 | $51 | $85.785 | $39.67 | 116.25% |
| 2023-02-24 | 14 | $139 | $51 | $85.5 | $39.67 | 115.53% |
| 2023-03-09 | 14 | $139 | $51 | $85.285 | $39.67 | 114.99% |
| 2023-03-13 | 14 | $139 | $51 | $85.428 | $39.67 | 115.35% |
| 2023-04-17 | 14 | $139 | $58 | $86.571 | $39.67 | 118.23% |
| 2023-04-24 | 14 | $141 | $58 | $89.357 | $39.67 | 125.25% |
| 2023-05-02 | 14 | $141 | $58 | $90.357 | $39.67 | 127.77% |
| 2023-05-05 | 14 | $141 | $58 | $91.285 | $39.67 | 130.11% |
| 2023-05-08 | 14 | $156 | $58 | $96.785 | $39.67 | 143.98% |
| 2023-05-09 | 14 | $156 | $76 | $104.142 | $39.67 | 162.52% |
| 2023-06-06 | 14 | $156 | $76 | $105 | $39.67 | 164.68% |
| 2023-07-17 | 14 | $156 | $76 | $105.071 | $39.67 | 164.86% |
| 2023-07-21 | 14 | $156 | $40 | $99.571 | $39.67 | 151% |
| 2023-07-31 | 14 | $156 | $40 | $95.714 | $39.67 | 141.28% |
| 2023-08-01 | 14 | $141 | $32 | $85.071 | $39.67 | 114.45% |
| 2023-08-02 | 14 | $141 | $32 | $77.928 | $39.67 | 96.44% |
| 2023-08-03 | 14 | $141 | $32 | $73.857 | $39.67 | 86.18% |
| 2023-08-07 | 14 | $141 | $29 | $73.642 | $39.67 | 85.64% |
| 2023-08-29 | 14 | $141 | $29 | $73 | $39.67 | 84.02% |
| 2023-09-08 | 13 | $95 | $29 | $66.857 | $39.67 | 68.53% |
| 2023-09-15 | 13 | $95 | $29 | $67.642 | $39.67 | 70.51% |
The Trend in the Analyst Price Target
APLS's average price target has moved down $7.27 over the prior 31 weeks.
APLS reports an average of 62.07% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-13 | 13 | 113 | 40 | 78.153 | 58.72 | 33.09% |
| 2022-11-08 | 13 | 123 | 40 | 77.923 | 47.11 | 65.41% |
| 2023-02-22 | 14 | 123 | 51 | 84.142 | 65.82 | 27.84% |
| 2023-05-05 | 14 | 141 | 58 | 91.285 | 93.18 | -2.03% |
| 2023-08-01 | 14 | 141 | 32 | 85.071 | 24.22 | 251.24% |
APLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.69 | 8 | 1 | 4 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
APLS's average broker recommendation rating worsened by 0.23 over the prior 15 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, APELLIS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -6394.31% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, APELLIS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 6180.15% of them.
- APELLIS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 6062.69% of Pharmaceutical Products stocks.
- APLS has a greater average analyst price target than 5886.72% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to APELLIS PHARMACEUTICALS INC are ZLAB, RDY, and BGNE.
View All Top Stocks by Price Target
What is the outlook for APLS? Use POWR Ratings for clearer insight into price direction.